4.6 Article

Impact of early kangaroo mother care versus standard care on survival of mild-moderately unstable neonates <2000 grams: A randomised controlled trial

期刊

ECLINICALMEDICINE
卷 39, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.eclinm.2021.101050

关键词

Neonate; Newborn; Premature; Survival; Mortality; Kangaroo Mother Care; Kangaroo method; Skin-to-skin contact

资金

  1. Wellcome Trust [200116/Z/15/Z]
  2. London School of Hygiene & Tropical Medicine (LSHTM), London, UK [QA1078]
  3. Wellcome Trust [200116/Z/15/Z] Funding Source: Wellcome Trust

向作者/读者索取更多资源

This study conducted in The Gambia aimed to investigate the impact of early kangaroo mother care on the survival of neonates weighing less than 2000g. The findings showed that there was no significant difference in the mortality rate within 28 days among neonates receiving the intervention compared to those receiving standard care. There were also no notable differences in secondary outcomes and serious adverse events between the two groups.
Background: Understanding the effect of early kangaroo mother care on survival of mild-moderately unstable neonates <2000 g is a high-priority evidence gap for small and sick newborn care. Methods: This non-blinded pragmatic randomised clinical trial was conducted at the only teaching hospital in The Gambia. Eligibility criteria included weight <2000g and age 1-24 h with exclusion if stable or severely unstable. Neonates were randomly assigned to receive either standard care, including KMC once stable at >24 h after admission (control) versus KMC initiated <24 h after admission (intervention). Randomisation was stratified by weight with twins in the same arm. The primary outcome was all-cause mortality at 28 postnatal days, assessed by intention to treat analysis. Secondary outcomes included: time to death; hypothermia and stability at 24 h; breastfeeding at discharge; infections; weight gain at 28d and admission duration. The trial was prospectively registered at www.clinicaltrials.gov (NCT03555981). Findings: Recruitment occurred from 23rd May 2018 to 19th March 2020. Among 1,107 neonates screened for participation 279 were randomly assigned, 139 (42% male [n = 59]) to standard care and 138 (43% male [n = 59]) to the intervention with two participants lost to follow up and no withdrawals. The proportion dying within 28d was 24% (34/139, control) vs. 21% (29/138, intervention) (risk ratio 0.84, 95% CI 0.55 1.29, p = 0.423). There were no between-arm differences for secondary outcomes or serious adverse events (28/139 (20%) for control and 30/139 (22%) for intervention, none related). One-third of intervention neonates reverted to standard care for clinical reasons. Interpretation: The trial had low power due to halving of baseline neonatal mortality, highlighting the importance of implementing existing small and sick newborn care interventions. Further mortality effect and safety data are needed from varying low and middle-income neonatal unit contexts before changing global guidelines. Funding: This research was funded in whole by The Wellcome Trust [Ref. 200116/Z/15/Z] as a Research Training Fellowship to HB. For the purpose of open access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission. We have not been paid to write this article by a pharmaceutical company or other agency. The sponsor was London School of Hygiene & Tropical Medicine (LSHTM), London, UK. Reference: QA1078. (c) 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据